Mexico Biomaterials in Healthcare Market Analysis Report [2022-30] I Insights10

Mexico Biomaterials in Healthcare Market Analysis

$ 3999

The Mexico Biomaterials in Healthcare Market is expected to witness growth from $2.34 Bn in 2022 to $6.43 Bn in 2030 with a CAGR of 13.45% for the forecasted year 2022-2030. Research and development spending have increased in Mexico, including in the area of biomaterials. By encouraging the creation of fresh and cutting-edge biomaterials, this is anticipated to fuel growth in the Mexico healthcare biomaterials market. The market is segmented by type and by application. Some key players in this market include: BIOMEDICA MEXICANA S.A DE C.V, Medstent, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

ID: IN10MXMD003 CATEGORY: Medical Devices GEOGRAPHY: Mexico AUTHOR: Jigyasu Bhandari

Buy Now

Mexico Biomaterials in Healthcare Market Executive Analysis

The Mexico Biomaterials in Healthcare Market size is at around $2.34 Bn in 2022 and is projected to reach $6.43 Bn in 2030, exhibiting a CAGR of 13.45% during the forecast period. Compared to an average increase of 0.9% across the Organization for Economic Cooperation and Development region, health spending in Mexico increased considerably from 5.4% in 2019 to 6.2% in 2020. 6.2% of Mexico's GDP (gross domestic product) was allocated to healthcare in 2020. Despite the fact that the percentage has dropped from 55% to 45%, the typical Mexican still has to pay out-of-pocket expenses.

In the creation of biodegradable plastics, Mexico is a global leader. Drug delivery, tissue engineering, and wound healing are just a few of the many uses for these compounds. A pioneer in the creation of nanomaterials for medicinal use is Mexico. Due to their special qualities, these materials can be used for imaging, diagnostics, and drug administration. Hydrogels are materials with a high-water absorption capacity and are frequently used in drug administration and tissue engineering. Leading the way in the creation of hydrogels for medicinal use is Mexico. Biomaterials are essential in the creation of medical devices, which are a thriving business in Mexico. Implants, surgical instruments, and diagnostic tools are just a few of the medical products that are created using biomaterials. In order to encourage tissue regeneration and restoration, biomaterials are used in wound healing. Additionally, they can be used to stop infections and lessen damage.

mexico biomaterials in healthcare market

Market Dynamics

Market Growth Drivers

Research and development spending have increased in Mexico, including in the area of biomaterials. By encouraging the creation of fresh and cutting-edge biomaterials, this is anticipated to fuel growth in the Mexico healthcare biomaterials market. The aging population and growing prevalence of chronic diseases in Mexico are driving up the demand for medical implants. The market for biomaterials in healthcare is anticipated to expand as a result of the widespread use of these materials in the creation of medical implants. Due to its affordable healthcare and proximity to the United States, Mexico is frequently chosen for medical tourism. As more patients seek medical care in Mexico, this is anticipated to fuel market development in the biomaterials sector of the healthcare industry. The creation of biodegradable polymers and nanomaterials is just two examples of recent significant developments in the development of biomaterials. The range of applications for biomaterials is anticipated to increase as a result of these technological developments, which will fuel growth in the Biomaterials in Healthcare market.

Market Restraints

Manufacturers in Mexico's Biomaterials in Healthcare market might only have a few financing options for new biomaterials product development and research. This may hinder their capacity for innovation and new product development. It may be challenging for manufacturers to create a presence on the market due to competition from well-established products.

Competitive Landscape

Key Players

BIOMEDICA MEXICANA S.A DE C.V. (MX)
Medstent (MX)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Recent Notable Deals

2022: Consensus Orthopaedics, a Mexican manufacturer of orthopaedic devices, was taken over by Zimmer Biomet Holdings Inc. for an undisclosed sum, acquiring a 50% share. The influence of Zimmer Biomet will be boosted in Mexico as a result of this acquisition, and its orthopaedic product line will be increased.

Healthcare Policies and Regulatory Landscape

The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is in charge of Mexico's biomaterials regulatory system. The quality, effectiveness, and safety of medical devices, including biomaterials, distributed in Mexico, are the responsibility of COFEPRIS. Manufacturers must adhere to local laws and acquire COFEPRIS approval in order to sell biomaterials in Mexico. The approval procedure entails presenting proof of the biomaterial's quality, effectiveness, and safety as well as, if necessary, running clinical trials. The use of biomaterials in healthcare in Mexico is governed by COFEPRIS in addition to other regulatory organizations like the National Institute of Medical Sciences and Nutrition Salvador Zubiran (INCMNSZ). The INCMNSZ is in charge of undertaking studies and formulating regulations pertaining to the utilization of medical devices, including biomaterials, in the nation.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Mexico market in 2019. The growing geriatric population Mexicoly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.